Our Pricing

Ozempic to Mounjaro Conversion Chart: Safe Switching Guidance

If you're considering switching medications, our ozempic to mounjaro conversion chart uk provides clear, clinically-backed guidance on safe dose transitions. At Cured Pharmacy, our UK prescribers assess your current treatment and recommend the appropriate Mounjaro starting dose, with transparent pricing from £135.00 and £10 off your first order.

Understanding the Ozempic to Mounjaro Conversion Chart UK

Switching from Ozempic (semaglutide) to Mounjaro (tirzepatide) requires careful dose consideration, as these medications work through different receptor pathways. Ozempic activates GLP-1 receptors alone, whilst Mounjaro is the first dual GIP/GLP-1 receptor agonist licensed by the MHRA in the UK [1]. This dual mechanism produces enhanced metabolic effects but means the medications are not directly equivalent milligram-for-milligram.

Most UK prescribers recommend starting Mounjaro at 2.5mg weekly regardless of your previous Ozempic dose, as this is the licensed initiation dose designed to minimise gastrointestinal side effects [2]. After four weeks, your prescriber will typically increase you to 5mg weekly, with further titration based on your response and tolerability. This cautious approach ensures your body adapts to the dual-receptor activation safely.

Clinical evidence from the SURPASS-2 head-to-head trial demonstrated that Mounjaro 15mg produced significantly greater weight reduction than Ozempic 1mg — an average of 12.4kg versus 6.2kg over 40 weeks [1]. However, your UK prescriber will determine your optimal maintenance dose through regular assessment, not simply by converting your previous Ozempic dose arithmetically.

Recommended Starting Doses When Switching from Ozempic to Mounjaro

The MHRA-approved prescribing information for Mounjaro specifies a universal starting dose of 2.5mg once weekly, irrespective of your previous GLP-1 treatment [2]. This applies whether you were on Ozempic 0.25mg, 0.5mg, 1mg, or even the higher 2mg dose. The rationale is that tirzepatide's dual-agonist mechanism requires a specific titration schedule to optimise tolerability.

Your transition timeline typically follows this pattern: continue your final Ozempic injection as scheduled, then begin Mounjaro 2.5mg one week later. After four weeks on 2.5mg, your prescriber will increase you to 5mg weekly, provided you're tolerating the medication well. Further dose escalations to 7.5mg, 10mg, 12.5mg, or 15mg occur at four-week intervals, guided by your weight loss response and side effect profile [2].

Some patients ask whether they can start at a higher Mounjaro dose if they were already on Ozempic 1mg or 2mg. UK prescribers generally advise against this approach, as clinical trials establishing Mounjaro's safety profile used the standardised 2.5mg starting dose [1]. Skipping this initial titration phase may increase your risk of nausea, vomiting, and treatment discontinuation.

Timing Your Switch: When to Take Your First Mounjaro Dose

Both Ozempic and Mounjaro have approximately one-week duration of action, so your UK prescriber will advise taking your first Mounjaro injection seven days after your last Ozempic dose. This prevents medication overlap whilst ensuring continuous GLP-1 receptor coverage. If you've missed your final Ozempic dose or there's been a gap in treatment, inform your prescriber during your consultation, as they may adjust your Mounjaro starting protocol accordingly.

Why Patients Switch from Ozempic to Mounjaro in the UK

The primary reason UK patients transition to Mounjaro is enhanced efficacy. In the SURPASS-2 trial, patients switching to tirzepatide achieved nearly double the weight reduction compared to those remaining on semaglutide 1mg [1]. At the highest Mounjaro dose of 15mg weekly, participants lost an average of 12.4kg versus 6.2kg with Ozempic 1mg over 40 weeks — a clinically meaningful difference for patients seeking greater results.

Some patients also report improved tolerability with Mounjaro despite its dual-agonist mechanism. Whilst gastrointestinal side effects occur with both medications, the structured titration schedule for tirzepatide may help some individuals adapt more comfortably than they experienced with semaglutide dose escalations. However, this is highly individual, and your UK prescriber will monitor your response closely during the transition.

Supply considerations have also influenced switching decisions in the UK. During periods when Ozempic faced availability constraints, some prescribers recommended transitioning stable patients to Mounjaro to ensure continuity of treatment. At Cured Pharmacy, we maintain stock of both medications and can advise on the most suitable option based on current availability and your clinical needs.

Mounjaro Dosing Schedule and Titration After Ozempic

Mounjaro's titration schedule is more granular than Ozempic's, with six available dose strengths compared to Ozempic's four. After your initial 2.5mg starting dose, you'll progress through 5mg, 7.5mg, 10mg, 12.5mg, and potentially 15mg at four-week intervals [2]. This allows your UK prescriber to fine-tune your dose based on weight loss velocity and side effect tolerance.

The maintenance dose varies considerably between patients. Some individuals achieve their weight loss goals on 7.5mg or 10mg weekly and remain at that dose long-term. Others require titration to 12.5mg or 15mg for optimal results. Your prescriber will assess your progress at each dose level, considering factors such as percentage body weight reduction, plateau patterns, and gastrointestinal tolerability [2].

Unlike Ozempic, where many patients reach the maximum 1mg or 2mg dose, Mounjaro patients may stabilise at mid-range doses. Clinical data shows significant efficacy across the dose range — even the 10mg dose produced greater weight loss than Ozempic 1mg in head-to-head trials [1]. Your UK prescriber will determine your optimal long-term dose through regular clinical review rather than automatically escalating to the maximum strength.

What to Expect During the First Month on Mounjaro

During your initial four weeks on Mounjaro 2.5mg, you may notice reduced appetite and early weight loss, though results are typically more modest than at higher doses. Some patients experience mild nausea, particularly in the first week after injection, which usually diminishes as your body adapts. Your UK prescriber will review your tolerability before approving dose escalation to 5mg at week five, ensuring you're ready for the increased receptor activation.

Managing Side Effects When Switching to Mounjaro from Ozempic

Even if you tolerated Ozempic well, you may experience transient side effects when switching to Mounjaro due to the additional GIP receptor agonism. The most common effects are gastrointestinal — nausea, diarrhoea, constipation, and reduced appetite — which typically peak within the first few days after each dose increase and improve over subsequent weeks [2].

To minimise side effects during your transition, UK prescribers recommend several practical strategies. Eat smaller, more frequent meals rather than large portions. Avoid high-fat, greasy, or heavily spiced foods, which can exacerbate nausea. Stay well-hydrated, particularly if you experience vomiting or diarrhoea. Inject your Mounjaro dose in the evening rather than morning, so peak nausea occurs during sleep when it's less disruptive.

If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis (intense upper abdominal pain radiating to your back), contact your prescriber immediately. Whilst serious side effects are uncommon, they require prompt clinical assessment. Your UK prescriber may recommend remaining at your current dose longer before escalating, or occasionally reducing to the previous dose if side effects are limiting your quality of life [2].

Getting Your Mounjaro Prescription at Cured Pharmacy

Switching from Ozempic to Mounjaro requires a new prescription from a UK-registered prescriber, even if you have an existing Ozempic prescription from your GP or another provider. At Cured Pharmacy, our online consultation takes under three minutes and covers your current treatment, weight loss progress, medical history, and any side effects you've experienced on Ozempic.

Our UK clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), will review your consultation and determine whether Mounjaro is clinically appropriate for you. If approved, we'll issue your prescription and dispense genuine UK-licensed Mounjaro KwikPens directly to your address in discreet packaging. Your first order includes £10 off, bringing the starting price to £135.00 with transparent pricing shown before you complete your consultation.

We stock all Mounjaro dose strengths from 2.5mg through to 15mg, ensuring continuity as you titrate upwards. Your prescription will typically cover your initial 2.5mg dose with instructions for follow-up assessment before progressing to 5mg. Repeat prescriptions are managed through brief clinical reviews, allowing your prescriber to monitor your progress and adjust your dose as needed throughout your weight loss journey.

Why Choose Cured Pharmacy for Your Mounjaro Treatment

As a fully registered UK pharmacy (GPhC 9012511), we guarantee genuine MHRA-licensed Mounjaro at the lowest UK prices. Unlike some providers, we show exact pricing before your consultation — no hidden fees or surprise charges. Our clinical team has supported thousands of patients through GLP-1 transitions, providing the expert guidance you need when switching from Ozempic to Mounjaro safely and effectively.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): A Randomised, Open-Label, Phase 3 Trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6
2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/14547

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or switching between treatments.